Now showing items 1-2 of 2

    • Is locally advanced head-neck cancer one more candidate for accelerated hypofractionation? 

      KOUKOURAKIS I.M., ZYGOGIANNI A., KOULOULIAS V., KYRGIAS G., PANTELIADOU M., NANOS C., ABATZOGLOU I., KOUKOURAKIS M.I. (2021)
      Background/Aim: Hypofractionated accelerated radiotherapy (HypoAR) is widely applied for the treatment of early laryngeal cancer. Its role in locally advanced head-neck cancer (LA-HNC) is unexplored. Patients and Methods: ...
    • Radiation-induced oral mucositis in head and neck cancer patients. Five years literature review 

      Gkantaifi A., Vardas E., Alongi F., Tsoukalas N., Saraireh H.H., Charalampakis N., Lövey J., Hajiioannou J., Kyrodimos E., Tsanadis K., Mauri D., Christopoulos C., Iliadis G., Tolia M. (2021)
      Backround: Radiation-induced oral mucositis consists of a series of relatively frequent side effects after head and neck cancer radiotherapy and has an adverse impact on both regular treatment process and the quality of ...